Mark Lowdell

Mark Lowdell

Founder bij INMUNE BIO, INC.

Vermogen: 17 M $ op 29-02-2024

61 jaar
Consumer Services
Health Technology
Health Services

Profiel

Founder of 6 different companies, notably: INmune Bio, Inc., Achilles Therapeutics Plc and Kuur Therapeutics Ltd.
Mark Lowdell is an entrepreneur and currently occupies the position of Chief Scientific & Manufacturing Officer at INmune Bio, Inc. (which he founded in 2015) and Scientific Founder at Achilles Therapeutics Plc.
Dr. Lowdell is also on the board of Autolomous Ltd.
and Professor at University College London, Director-Cellular Therapy at Royal Free London NHS Foundation Trust, Director-Centre for Cell, Gene & Tissue at Royal Free Hospital Medical School and Vice President of International Society For Cell & Gene Therapy.
He received a doctorate from St Bartholomew's Hospital Medical College and a doctorate from Blizard Institute.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
17-04-2023 1 496 383 ( 8.30% ) 17 M $ 29-02-2024

Actieve functies van Mark Lowdell

BedrijvenFunctieBegin
INMUNE BIO, INC. Founder 01-09-2015
ACHILLES THERAPEUTICS PLC Founder 01-11-2020
University College London Corporate Officer/Principal 01-01-1994
Corporate Officer/Principal 01-02-2009
Royal Free Hospital Medical School Corporate Officer/Principal -
International Society For Cell & Gene Therapy Corporate Officer/Principal -
Autolomous Ltd. Founder 01-02-2019
Alle actieve functies van Mark Lowdell

Eerdere bekende functies van Mark Lowdell

BedrijvenFunctieEinde
Founder -
Immune Ventures Ltd. Founder -
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░ -
Ervaring van Mark Lowdell in detail bekijken

Opleiding van Mark Lowdell

St Bartholomew's Hospital Medical College Doctorate Degree
Blizard Institute Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Mark Lowdell in detail bekijken

Connecties

100 +

Eerstegraads connecties

12

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
INMUNE BIO, INC.

Health Technology

ACHILLES THERAPEUTICS PLC

Health Technology

Bedrijven in privébezit6

Health Technology

Health Services

Health Technology

Immune Ventures Ltd.

International Society For Cell & Gene Therapy

Autolomous Ltd.

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Mark Lowdell